Surgery and OncologySurgery and OncologyХирургия и онкология2949-5857Publishing House ABV Press5610.17650/2220-3478-2012-0-3-46-50CASE REPORTКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯTreatment tactics in patient with rectal cancer complicating ulcerative colitisКлиническое наблюдение лечения больного раком прямой кишки, возникшим на фоне неспецифического язвенного колитаBarsukovYu. A.БарсуковЮ. А.
Russian Federation
AliyevV. A.АлиевВ. А.
Russian Federation
AtroshchenkoA. O.АтрощенкоА. О.
Russian Federation
TatayevI. Sh.ТатаевИ. Ш.
Russian Federation
MazurovS. T.МазуровС. Т.
Russian Federation
OvchinnikovaA. I.ОвчинниковаА. И.
Russian Federation
anna.mma@mail.ruN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва280220121346502802201528022015Copyright ©; 2012, ABV-pressCopyright ©; 2012, АБВ-пресс2012ABV-pressАБВ-прессhttps://onco-surgery.info/jour/about/editorialPolicieshttps://onco-surgery.info/jour/article/view/56

A successful treatment of a young patient with a 15-year anamnesis of ulcerative colitis, who has been diagnosed with rectal cancer, is presented in this case report. A non-standard surgical intervention has been performed following all principles of oncologic surgery. A subtotal colectomy has been performed with ultra-low anterior resection of rectum. Ascendoanal anastomosis has been performed forming the neo-rectum. There were no complications in postoperative period. Considering disease stage (T3N1M0) adjuvant XELOX was administered for 6 months along with 2 cycles of prophylactic treatment with 5-aminosalycilic acid. During 2-years follow-up there are no signs of rectal cancer and ulcerative colitis progression. After pelvic electrostimulation defecation frequency decreased to 3–4 times per day, a patient has complete social rehabilitation.

rectal cancerulcerative colitisultra-low anterior resection with coloanal anastomosisneorectumsurgerycombined treatmentрак прямой кишкинеспецифический язвенный колитбрюшно-анальная резекциянеоректумхирургическое лечениекомплексное лечение1. Давыдов М.И., Аксель Е.М. Вестник ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН 2010; 21:2(80)(прил. 1).Давыдов М.И., Аксель Е.М. Вестник ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН 2010; 21:2(80)(прил. 1).2. Лагошный А.Т. Современный подход к лечению аденом прямой и ободочнойЛагошный А.Т. Современный подход к лечению аденом прямой и ободочнойкишки. Дис. … канд. мед. наук. М., 1988. С. 29–34, 71–73.3. Мухин Н.А. Внутренние болезни. Т. 2. М.: ГЭОТАР-Медиа, 2007. С. 631–635.Мухин Н.А. Внутренние болезни. Т. 2. М.: ГЭОТАР-Медиа, 2007. С. 631–635.4. Lochs H., Mayer M., Fleig W.E. et al. Gastroenterology 2000;118(2):264–73.Lochs H., Mayer M., Fleig W.E. et al. Gastroenterology 2000;118(2):264–73.5. Sandborn W.J., Tremaine W.J., Wolf D.C. et al. Gastroenterology 1999;17(3):527–35.Sandborn W.J., Tremaine W.J., Wolf D.C. et al. Gastroenterology 1999;17(3):527–35.6. Юхвидова Ж.М., Левитан М.X. Неспецифический язвенный колит. М.: Меди-Юхвидова Ж.М., Левитан М.X. Неспецифический язвенный колит. М.: Меди-цина, 1969.7. Kornbluth A.A., Sаlomon P., Sacks H.S. et al. Meta-analysis of the effectivenessKornbluth A.A., Sаlomon P., Sacks H.S. et al. Meta-analysis of the effectivenessof current drug therapy of ulcerative colitis. J Clin Gastroenterol 1993;16(3):215–8.8. Sandborn W.J. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflam Bowel Dis 1995; 1:48-63.Sandborn W.J. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflam Bowel Dis 1995; 1:48-63.